会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 30. 发明授权
    • Method of promoting hematopoiesis using derivatives of human chorionic
gonadotropin
    • 使用人绒毛膜促性腺激素衍生物促进造血的方法
    • US5968513A
    • 1999-10-19
    • US709924
    • 1996-09-09
    • Robert C. GalloJoseph BryantYanto Lunardi-Iskandar
    • Robert C. GalloJoseph BryantYanto Lunardi-Iskandar
    • A61K38/00A61K38/24A61K48/00A61K38/12C07K7/64
    • A61K38/24A61K48/00Y10S514/885
    • The present invention relates to methods of treating or preventing diseases or disorders associated with hematopoietic deficiency by administration of human chorionic gonadotropin, .beta.-human chorionic gonadotropin or a peptide containing a sequence of a portion of .beta.-human chorionic gonadotropin. The invention also relates to methods of treating or preventing diseases or disorders associated with hematopoietic deficiency by administration of hematopoietic cells, the numbers of which have been increased by contacting the cells with human chorionic gonadotropin, .beta.-human chorionic gonadotropin or a peptide containing a sequence of a portion of .beta.-human chorionic gonadotropin. The invention also provides assays for the utility of particular human chorionic gonadotropin preparations in the treatment or prevention of hematopoietic deficiencies or in the increasing of hematopoietic cell numbers in vitro. Pharmaceutical compositions and methods of administration of are also provided.
    • 本发明涉及通过施用人绒毛膜促性腺激素,β-人绒毛膜促性腺激素或含有一部分β-人绒毛膜促性腺激素序列的肽来治疗或预防与造血缺陷相关的疾病或病症的方法。 本发明还涉及通过给予造血细胞来治疗或预防与造血缺陷相关的疾病或病症的方法,所述造血细胞的数量通过使细胞与人绒毛膜促性腺激素接触而增加,β-人绒毛膜促性腺激素或含有序列的肽 的一部分β-人绒毛膜促性腺激素。 本发明还提供特异性人绒毛膜促性腺激素制剂用于治疗或预防造血缺陷或增加体外造血细胞数量的测定。 还提供了药物组合物和给药方法。